Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 17 studies | 45% ± 20% | |
oligodendrocyte | 17 studies | 61% ± 19% | |
glutamatergic neuron | 12 studies | 44% ± 19% | |
endothelial cell | 6 studies | 38% ± 15% | |
GABAergic neuron | 6 studies | 44% ± 20% | |
neuron | 5 studies | 33% ± 12% | |
interneuron | 4 studies | 52% ± 9% | |
pericyte | 3 studies | 65% ± 19% | |
oligodendrocyte precursor cell | 3 studies | 21% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 16 studies | 43% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 3902.60 | 2635 / 2642 | 97% | 16.12 | 686 / 705 |
adrenal gland | 12% | 53.66 | 30 / 258 | 3% | 0.12 | 8 / 230 |
bladder | 0% | 0 | 0 / 21 | 5% | 0.38 | 26 / 504 |
kidney | 0% | 0 | 0 / 89 | 2% | 0.16 | 22 / 901 |
liver | 0% | 0 | 0 / 226 | 2% | 0.11 | 9 / 406 |
esophagus | 0% | 0 | 0 / 1445 | 2% | 0.03 | 3 / 183 |
prostate | 0% | 1.47 | 1 / 245 | 1% | 0.04 | 6 / 502 |
uterus | 0% | 0 | 0 / 170 | 2% | 0.46 | 7 / 459 |
thymus | 0% | 0 | 0 / 653 | 1% | 0.03 | 8 / 605 |
eye | 0% | 0 | 0 / 0 | 1% | 0.03 | 1 / 80 |
pancreas | 0% | 0 | 0 / 328 | 1% | 0.11 | 2 / 178 |
lung | 0% | 0 | 0 / 578 | 1% | 0.03 | 10 / 1155 |
skin | 0% | 0 | 0 / 1809 | 1% | 0.03 | 3 / 472 |
intestine | 0% | 0 | 0 / 966 | 0% | 0.00 | 2 / 527 |
stomach | 0% | 0 | 0 / 359 | 0% | 0.01 | 1 / 286 |
ovary | 0% | 0 | 0 / 180 | 0% | 0.01 | 1 / 430 |
breast | 0% | 0 | 0 / 459 | 0% | 0.00 | 2 / 1118 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007194 | Biological process | negative regulation of adenylate cyclase activity |
GO_0007196 | Biological process | adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway |
GO_0007216 | Biological process | G protein-coupled glutamate receptor signaling pathway |
GO_0051966 | Biological process | regulation of synaptic transmission, glutamatergic |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0099170 | Biological process | postsynaptic modulation of chemical synaptic transmission |
GO_0010467 | Biological process | gene expression |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0043197 | Cellular component | dendritic spine |
GO_0042734 | Cellular component | presynaptic membrane |
GO_0014069 | Cellular component | postsynaptic density |
GO_0097449 | Cellular component | astrocyte projection |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_0030424 | Cellular component | axon |
GO_0001641 | Molecular function | group II metabotropic glutamate receptor activity |
GO_0008066 | Molecular function | glutamate receptor activity |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0005246 | Molecular function | calcium channel regulator activity |
GO_0097110 | Molecular function | scaffold protein binding |
Gene name | GRM3 |
Protein name | Metabotropic glutamate receptor 3 (mGluR3) Metabotropic glutamate receptor 3 Glutamate metabotropic receptor 3 |
Synonyms | GPRC1C hCG_17203 tcag7.244 MGLUR3 |
Description | FUNCTION: G-protein coupled receptor for glutamate. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling inhibits adenylate cyclase activity. . FUNCTION: G-protein coupled receptor for glutamate. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling inhibits adenylate cyclase activity. . |
Accessions | A4D1D0 ENST00000439827.1 [Q14832-2] ENST00000361669.7 [Q14832-1] ENST00000441140.1 C9J2I2 ENST00000454217.1 C9JUH9 ENST00000421579.1 Q14832 C9JIT1 |